CNBC
US · 23 mins ago
✦ 78◉ Centre
Novo Nordisk says high-dose Wegovy helped some patients lose nearly 28% of their weight
78Accuracy
0Ratings
0Comments
AI Analysis
Accuracy 78/100
Partisan intensity 35/100
ObjectivePartisan
◉ Centre ✓ Fair headline
Novo Nordisk has released clinical data showing that a higher dose of its obesity medication Wegovy helped some patients achieve weight loss of nearly 28%, potentially strengthening the drug's market position.
Novo Nordisk says high-dose Wegovy helped some patients lose nearly 28% of their weight
Novo Nordisk released new data that could help boost the case for the higher dose version of its blockbuster obesity injection Wegovy.
Discussion 0 comments
Sort:
?
No comments yet — be the first to start the discussion!